- Report
- January 2025
- 125 Pages
Global
From €3541EUR$3,999USD£3,060GBP
- Report
- May 2024
- 133 Pages
Global
From €3541EUR$3,999USD£3,060GBP
- Report
- May 2024
- 133 Pages
Global
From €3541EUR$3,999USD£3,060GBP
- Report
- May 2024
- 129 Pages
Global
From €3541EUR$3,999USD£3,060GBP
- Report
- April 2023
- 115 Pages
Global
From €4206EUR$4,750USD£3,635GBP
- Report
- August 2022
- 110 Pages
Global
From €4206EUR$4,750USD£3,635GBP
- Report
- August 2023
- 220 Pages
Global
€4246EUR$4,795USD£3,669GBP
- Report
- April 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,711GBP
- Report
- November 2023
- 150 Pages
Global
From €4295EUR$4,850USD£3,711GBP
- Report
- May 2025
- 83 Pages
Global
From €3500EUR$4,234USD£3,130GBP
- Report
- October 2024
- 94 Pages
Global
From €3500EUR$4,234USD£3,130GBP
The Hormone Therapy market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat conditions related to hormones, such as diabetes, thyroid disorders, and menopause. Hormone Therapy drugs are used to replace hormones that are not being produced in sufficient amounts by the body, or to block the action of hormones that are overproduced. These drugs are typically administered orally, through injections, or through topical creams.
Hormone Therapy drugs are used to treat a variety of conditions, including infertility, polycystic ovary syndrome, and growth hormone deficiency. They are also used to treat certain types of cancer, such as prostate cancer. Hormone Therapy drugs are often used in combination with other treatments, such as chemotherapy or radiation therapy.
Some of the companies in the Hormone Therapy market include Pfizer, Novo Nordisk, Merck, Sanofi, and Eli Lilly. Show Less Read more